Condition: Chronic Rhinosinusitis (CRS) · Sponsor: Medtronic
To confirm clinical safety and performance for the PROPEL family of products when used according to IFUs and standard of care in Japan.
This description comes directly from the study's public registry record.
Katherine Schiller · 763-526-8329 · katherine.schiller@medtronic.com
Amita Patel · amita.patel@medtronic.com
Always discuss trial participation with your own doctor first.
| Japanese Red Cross Asahikawa Hospital | Asahikawa, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07546682